Tumour necrosis factor-α Expression is associated with increased severity of periprosthetic breast capsular contracture

European Surgical Research

Volumn 45, Issue 3-4, 2010, Pages 327-332

  Tan, K T ^a   Wijeratne, D ^a   Shih, B ^a   Baildam, A D ^b   Bayat, A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Breast implants; Capsular contracture; Collagen type III; Complications; Fibrosis; Tumour necrosis factor

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 3ALPHA1; CONNECTIVE TISSUE GROWTH FACTOR; PARAFFIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST PROSTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; EMBEDDING; EXTRACELLULAR SPACE; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PERIPROSTHETIC BREAST CAPSULAR CONTRACTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WOUND COMPLICATION;

ADULT; BASE SEQUENCE; BREAST; BREAST IMPLANTS; COLLAGEN TYPE III; CONNECTIVE TISSUE GROWTH FACTOR; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IMPLANT CAPSULAR CONTRACTURE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958607941     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321009     Document Type: Article

References (27)

1. Gabriel SE, Woods JE, O'Fallon WM, et al: Complications leading to surgery after breast implantation. N Engl J Med 1997; 336: 677-682.
2. Nemecek JAR, Young VL: How safe are silicone breast implants? South Med J 1993; 86: 932-944.
3. Spear SL, Baker JL Jr: Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg 1995; 96: 1119-1124.
4. Zimman OA, Toblli J, Stella I, Ferder M, Ferder L, Inserra F: The effects of angiotensinconverting- enzyme inhibitors on the fibrous envelope around mammary implants. Plast Reconstr Surg 2007; 120: 2025-2033.
5. D'Andrea F, Nicoletti GF, Grella E, et al: Modification of cysteinyl leukotriene receptor expression in capsular contracture: preliminary results. Ann Plast Surg 2007; 58: 212-214.
6. Grella E, Grella R, Siniscalco D, et al: Modification of cysteinyl leukotriene receptors expression in capsular contracture: followup study and definitive results. Ann Plast Surg 2009; 63: 206-208.
7. Westermarck J, Hakkinen L, Fiers W, et al: TNF-R55-specific form of human tumor necrosis factor-α induces collagenase gene expression by human skin fibroblasts. J Invest Dermatol 1995; 105: 197-202.
8. Verrecchia F, Pessah M, Atfi A, et al: Tumor necrosis factor-α inhibits transforming growth factor-α /Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem 2000; 275: 30226-30231.
9. Abraham DJ, Shiwen X, Black CM, et al: Tumor necrosis factorα suppresses the induction of connective tissue growth factor by transforming growth factor-α in normal and scleroderma fibroblasts. J Biol Chem 2000; 275: 15220-15225.
10. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.
11. Zhang X, Ding L, Sandford AJ: Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Mol Biol 2005; 6: 4.
12. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
13. Gancedo M, Ruiz-Corro L, Salazar-Montes A, et al: Pirfenidone prevents capsular contracture after mammary implantation. Aesthetic Plast Surg 2008; 32: 32-40.
14. Vistnes LM, Ksander GA, Kosek J: Study of encapsulation of silicone rubber implants in animals. A foreign-body reaction. Plast Reconstr Surg 1978; 62: 580-588.
15. Lossing C, Hansson HA: Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast Reconstr Surg 1993; 91: 1277-1286.
16. Wolfram D, Rainer C, Niederegger H, Piza H, Wick G: Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmun 2004; 23: 81-91.
17. Prantl L, Schreml S, Fichtner-Feigl S, Pöppl N, Eisenmann-Klein M, Schwarze H, Füchtmeier B: Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg 2007; 120: 275-284.
18. Distler JHW, Schett G, Gay S, et al: The controversial role of tumor necrosis factorα in fibrotic diseases. Arthritis Rheum 2008; 58: 2228-2235.
19. Myllyharju J, Kivirikko KI: Collagens and collagen-related diseases. Ann Med 2001; 33: 7-21.
20. McCoy BJ, Person P, Kelman Cohen I: Collagen production and types in fibrous capsules around breast implants. Plast Reconstr Surg 1984; 73: 924-927.
21. Marshall WR, Godfrey M, Hollister DW, et al: Types of collagen in breast capsules. Ann Plast Surg 1989; 23: 401-405.
22. Broughton G II, Janis JE, Attinger CE: The basic science of wound healing. Plast Reconstr Surg 2006; 117(7 Suppl):12S-34S.
23. Mauviel A, Heino J, Kahari VM, et al: Comparative effects of Interleukin-1 and tumor necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 1991; 96: 243-249.
24. Kuhn A, Singh S, Smith PD, et al: Periprosthetic breast capsules contain the fibrogenic cytokines TGF-α 1 and TGF-α 2, suggesting possible new treatment approaches. Ann Plast Surg 2000; 44: 387-391.
25. Frangou J, Kanellaki M: The effect of local application of Mitomycin-C on the development of capsule around silicone implants in the breast: an experimental study in mice. Aesthetic Plast Surg 2001; 25: 118-128.
26. Ibrahim Canter H, Konas E, Bozdogan O, et al: Effect of slow-release 5-fluorouracil on capsule formation around silicone breast implants: an experimental study with mice. Aesthetic Plast Surg 2007; 31: 674-679.
27. Isom C, Kapoor V, Wilson L, et al: Breast implant capsules are partially composed of bone marrow-derived cells. Ann Plast Surg 2007; 58: 377-380.